Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a glucocorticosteroid for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis

Details for Australian Patent Application No. 2005232532 (hide)

International Classifications

Event Publications

8 March 2007 Section 223 Application Allowed

Epigenesis Pharmaceuticals Llc The time in which to enter the National Phase has been extended to 30 Jan 2007. Address for service in Australia - FISHER ADAMS KELLY Level 29 Comalco Place 12 Creek Street Brisbane QLD 4000

22 March 2007 PCT application entered the National Phase

PCT publication WO2005/099720 Priority application(s): WO2005/099720

2 December 2010 Application Accepted

Published as AU-B-2005232532

31 March 2011 Standard Patent Sealed

11 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.